Today's other deal a direct investment of USD40m
8 April 2024, London, Geneva & Jersey: Medicxi, a leading European life sciences investment firm, today announces an investment of $40 million in D3 Bio, a biotechnology company based in Shanghai, China. D3 Bio is focused on the discovery, development, and registration of innovative medicines in oncology and immunology. The investment will accelerate the development of D3 Bio’s innovative pipeline of oncology compounds. Francesco De Rubertis, Partner at Medicxi, will join the Board of D3 Bio.
https://www.medicxi.com/news/medicxi-announces-40m-investment-in-d3-bio
Today's other deal a direct investment of USD40m8 April 2024,...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 51666 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 76969 | 2 |
View Market Depth
| Last trade - 09.54am 06/05/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable